The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, mentorship, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

Novel Coronavirus / COVID-19 Resources

The INS Peer-Reviewed Journal

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online. The journal also has social media accounts on Twitter, Facebook, and Instagram.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Review Discusses Neural Interfaces for Upper Extremity Rehabilitation Robotics

May 15, 2020 - An invited review discusses what might be required to transition devices to restore upper limb control to a clinical market. The authors say characteristics of peripheral nerve interfaces and brain-machine interfaces could enable them to be concurrently developed. (Source: Muscle & Nerve)

Registry Study Compares Depression Scores Between Groups of Bipolar Patients, With or Without Neurostimulation

May 20, 2020 - LivaNova announced publication of a study based on a 5-year prospective registry that compared treatment as usual, with or without additional vagus nerve stimulation, in patients with treatment-resistant bipolar disorder. (Source: Mass Device)

Journal Publishes 12-Month Results for Sacral Neuromodulation System

May 19, 2020 - Axonics Modulation Technologies, Inc. announced 1-year results were published from the safety and efficacy study of its rechargeable sacral neuromodulation system in patients with urinary urge incontinence. Axonics also plans to launch a multicenter registry study in the U.S. to collect data on all approved indications.(Source: Olean Times Herald)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs

International Neuromodulation Society 3rd Interim Meeting, Oct. 23-25, 2020, Mumbai, India:

Last Updated on Monday, December 12, 2016 10:01 AM